ME1036
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
ME1036, a novel parenteral carbapenem, was developed for the treatment of MRSA and vancomycin-intermediate S. aureus (VISA). A…
We have correlated the binding affinities of ME1036, a carbapenem, to the penicillin-binding proteins (PBPs) from Streptococcus…
fer of such strains from animal to meat products, e.g. during slaughtering. The characterization and comparison of plasmids in…
1. Sahm D, Draghi D, Thornsberry C. Activity of ME1036, a novel anti-MRSA carbapenem, against Gram-positive and Gram-negative…
ABSTRACT The efficacy of ME1036, a novel parenteral carbapenem, was compared with that of vancomycin by using a rabbit model of…
We investigated the antibacterial activities of 19 beta-lactams against three recombinant bacterial strains, in which three…
ME1036, formerly CP5609, is a novel parenteral carbapenem with a 7-acylated imidazo[5,1-b]thiazole-2-yl group directly attached…